LV-1053

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLV-1053
Drug Alias NameeEF2K inhibitor (Longevica Pharmaceuticals)LV-1053
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionElongation factor 2 inhibitors
TargetsElongation factor 2
Therapy Area/IndicationsHeart InjuriesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLongevica Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLongevica Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsHeart InjuriesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A